Alnylam Pharmace. buy kyron7htx
Summary
This prediction ended on 17.07.21 with a price of €150.10. With a performance of 116.51% the BUY prediction by kyron7htx was a big success. kyron7htx has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Alnylam Pharmace. | 7.640% | 7.640% | 21.450% | 49.314% |
iShares Core DAX® | 2.275% | 4.627% | 18.839% | 16.367% |
iShares Nasdaq 100 | 6.015% | 2.007% | 23.636% | 35.232% |
iShares Nikkei 225® | 4.456% | 3.598% | 12.437% | -0.660% |
iShares S&P 500 | 4.061% | 2.876% | 23.447% | 38.511% |
Comments by kyron7htx for this prediction
In the thread Alnylam Pharmace. diskutieren
Neueinstieg
nach Stopploss.
Stopped prediction by kyron7htx for Alnylam Pharmace.
Alnylam Pharmace.
05.02.19
07.02.19
07.02.19